Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Allient (ALNT) Research & Development (2016 - 2025)

Allient (ALNT) has disclosed Research & Development for 16 consecutive years, with $9.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Research & Development rose 3.27% to $9.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $38.8 million, a 2.33% decrease, with the full-year FY2025 number at $38.8 million, down 2.33% from a year prior.
  • Research & Development was $9.7 million for Q4 2025 at Allient, roughly flat from $9.7 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $20.6 million in Q4 2021 to a low of $94000.0 in Q3 2021.
  • A 5-year average of $8.9 million and a median of $9.6 million in 2025 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: surged 10221.28% in 2022, then plummeted 97.9% in 2023.
  • Allient's Research & Development stood at $20.6 million in 2021, then crashed by 53.02% to $9.7 million in 2022, then soared by 107.93% to $20.1 million in 2023, then plummeted by 53.58% to $9.3 million in 2024, then rose by 3.27% to $9.7 million in 2025.
  • Per Business Quant, the three most recent readings for ALNT's Research & Development are $9.7 million (Q4 2025), $9.7 million (Q3 2025), and $9.9 million (Q2 2025).